Cell Sorter for Next CT Products : Sangamo & Sony Biotechnology Journey

18 Jan 2023
Briefing 2
Sony Biotechnology Inc

Overview: Next Cell Therapy processes should start with a cell isolation multi-parameters selection to ensure the purity, a key attribute for patient safety. The development of Clinical/GMP grade equipment in close collaboration allows to achieve perfected equipment in line with the needs of cell therapy



12:30pm Panel

1:10pm Q&A



Nadia Lounnas-Mourey Ph.D  Associate Director Process development, Sangamo Therapeutics France

Aditi Singh, Ph.D, Global Senior Marketing Manager, Sony Biotechnology

Cedric Ait Mansour, Global Senior Manager Market Development – New Products, Sony Biotechnology


Nadia Lounnas-Mourey
Associate Director, Process Development
Sangamo Therapeutics
Aditi Singh
Global Senior Marketing Manager
Sony Biotechnology Inc
Cedric Ait Mansour
Global Senior Manager Market Development – New Products
Sony Biotechnology Inc